Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$12.74 - $15.12 $82,453 - $97,856
-6,472 Reduced 20.75%
24,717 $0
Q3 2022

Oct 28, 2022

SELL
$12.93 - $17.17 $42,358 - $56,248
-3,276 Reduced 9.51%
31,189 $447,000
Q2 2022

Aug 02, 2022

SELL
$13.53 - $23.34 $4,329 - $7,468
-320 Reduced 0.92%
34,465 $549,000
Q1 2022

Apr 27, 2022

BUY
$16.14 - $22.6 $661 - $926
41 Added 0.12%
34,785 $786,000
Q4 2021

Feb 18, 2022

SELL
$18.64 - $36.77 $31,352 - $61,847
-1,682 Reduced 4.62%
34,744 $652,000
Q3 2021

Nov 22, 2021

SELL
$32.83 - $43.0 $37,820 - $49,536
-1,152 Reduced 3.07%
36,426 $1.2 Million
Q2 2021

Aug 26, 2021

SELL
$34.41 - $44.03 $101,578 - $129,976
-2,952 Reduced 7.28%
37,578 $1.6 Million
Q1 2021

Apr 28, 2021

SELL
$37.29 - $47.19 $58,470 - $73,993
-1,568 Reduced 3.72%
40,530 $1.55 Million
Q4 2020

Jan 28, 2021

SELL
$34.3 - $44.09 $666,243 - $856,404
-19,424 Reduced 31.57%
42,098 $1.84 Million
Q3 2020

Oct 30, 2020

BUY
$27.86 - $39.35 $107,790 - $152,245
3,869 Added 6.71%
61,522 $2.42 Million
Q2 2020

Jul 31, 2020

BUY
$30.3 - $42.55 $709,353 - $996,138
23,411 Added 68.37%
57,653 $1.82 Million
Q1 2020

May 01, 2020

BUY
$30.0 - $54.18 $34,980 - $63,173
1,166 Added 3.53%
34,242 $1.21 Million
Q4 2019

Feb 07, 2020

BUY
$42.29 - $52.2 $4,313 - $5,324
102 Added 0.31%
33,076 $1.61 Million
Q3 2019

Oct 31, 2019

BUY
$42.06 - $51.64 $10,304 - $12,651
245 Added 0.75%
32,974 $1.57 Million
Q2 2019

Aug 02, 2019

SELL
$33.93 - $43.66 $56,459 - $72,650
-1,664 Reduced 4.84%
32,729 $0
Q1 2019

May 02, 2019

BUY
$26.74 - $41.32 $919,668 - $1.42 Million
34,393 New
34,393 $0
Q4 2018

Feb 06, 2019

SELL
$25.26 - $38.43 $584,011 - $888,501
-23,120 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$33.27 - $39.25 $769,202 - $907,460
23,120 New
23,120 $846,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.